- Round ID
- FR-00623
- Stage
- Series B
- Round name
- Series B
- Amount
- $30M
Dated funding evidence
Storm Therapeutics
Series B · $30M · 2022-12-01
Reported round$30MSeries B
- Disclosure date
- 2022-12-01
- Reported currency
- USD
- Companies House
- 09553473
- Evidence sources
- 2
2022-12-01Series B$30M
Resolved investor records
M VenturesLead investorPfizer VenturesLead investorTaiho VenturesLead investorCambridge Innovation CapitalLead investorFast Track InitiativeInvestorUTokyo Innovation PlatformInvestorSeroba Life SciencesInvestorIP GroupInvestor
Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- M Ventures, Pfizer Ventures, Taiho Ventures, Cambridge Innovation Capital
- Other investors
- Fast Track Initiative, UTokyo Innovation Platform, Seroba Life Sciences, IP Group
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.